Dechra Pharmaceuticals PLC
29 February 2008
29 February 2008
Dechra Pharmaceuticals PLC
(the 'Company')
The Company announces that the following Directors / PDMRs have today been
granted options to subscribe for ordinary shares of 1 pence each in the Company
in accordance with the terms of the Dechra Pharmaceuticals PLC Long Term
Incentive Plan (the Plan):
Name of Director / PDMR Number of Options Granted
Ian Page 37,975
Simon Evans 22,152
Ed Torr 20,253
Martin Riley 13,924
Mike Annice 12,362
Peter Graham 10,795
Giles Coley 10,127
Mike Eldred 12,226
Susan Longhofer 12,658
The vesting of the options is subject to the achievement of performance targets,
based on TSR over a three year measurement period and compared to the TSR of all
other companies within the FTSE Small Cap Index.
Enquiries:
Zoe Bamford
Company Secretary
01782 771100
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.